(Q45258050)
Statements
A randomised, double-blind, vehicle-controlled study to evaluate the efficacy and safety of MAS063D (Atopiclair) in the treatment of mild to moderate atopic dermatitis (English)
Belloni G
Pinelli S
scientific article published in January 2005